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Abstract 
Review on der(9)t(1;9)(q12;q12), with data on 
clinics. 
Clinics and pathology 
Disease 
Myeloid malignancies mainly. 
Phenotype/cell stem origin 
6 patients were diagnosed with chronic 
myeloproliferative disorders (MPD): polycythemia 
vera (PV) 5 cases (Rege-Cambrin et al., 1991;  
Najfeld et al., 2002;  Jacob et al., 2003; Sambani et 
al., 2005) and myelofibrosis (MF) 1 patient 
(Sambani et al., 2005). 1 patient was diagnosed with 
plasma cell leukemia (Heller et al., 2004) and 1 with 
follicular lymphoma (Mohamed et al., 2001) (Table 
1). ). 
Epidemiology 
Sporadic cases; found in 4 male and 4 female 
patients (sex ratio 1:1) aged 53 to 73 years. 
Prognosis 
Unknown, rare occurrence. 
Cytogenetics 
Cytogenetics morphological 
Presents as 2 normal chromosomes 1 and 9 and an 
extra der(9)t(1;9) chromosome in 7 out of 8 cases. 
Additional anomalies 
Sole abnormality in 2 MPD patients (Sambani et al., 
2005), associated with limited additional anomalies 
in the remaining MPD patients (each case 1): +8 
(Jacob et al., 2003), +9  (Najfeld et al., 2002), 
del(5)(q14q32)  (Rege-Cambrin et al., 1991) and 
del(11)(q22)  (Sambani et al., 2005); complex 
karyotypes in plasma cell leukemia and lymphoma 
patients. 




The unbalanced der(9)t(1;9)(q12;q12) is a rare but 
recurrent chromosome translocation, found mainly 
in chronic myeloproliferative neoplasms. The 
breakpoints in chromosomes 1 and 9 are within the 
constitutive heterochromatin bands that are 
notoriously unstable chromosomal regions and 
permit formation of complex and unstable 
chromosomal translocations.  Mostly, these 
rerrangements are unbalanced and accompanied by 
genomic imbalances, casually implicated in disease 
initiation or progression. The presence of an extra 
der(9)t(1;9)(q12;q12) results in trisomy of both 1q 
and 9p arms, therefore altered dosages of genes are 
likely to be involved in neoplastic processes. 
der(9)t(1;9)(q12;q12) is apparently secondary as 
mostly coexists with well-known primary 
abnormalities such as trisomy 8 or 9 or 5q deletion. 
The presence of either trisomy 9 or +9p suggests that 
gene-dosage effect of JAK2, located at 9p24.1 may 
contribute to MPD phenotype. In addition, the 
observation that MPD patients with 9/+9p trisomy 
are invariably JAK2V617F-positive (Campell et al., 
2006) imply a role for JAK2 cooperating mutation in 
myeloproliferative disorders. 
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Ref Sex/Age Disease Karyotype  
1. F/53  
Polycythemia 
vera 
47,XX,del(5)(q14q32),+der(9)t(1;9)(q12;q12)   
2. F/63  
Follicular 
lymphoma   
 




























Table 1. Reported patients with der(9)t(1;9)(q12;q12). 
Abbreviations: M., male; F., female; LN., lymph node. 1. Rege-Cambrin et al., 1991; 2. Mohamed et al., 2001; 3. Najfeld et al., 
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